Research Peptides for Sleep Research
Quick Answer
Sleep-specific peptide research is small next to the metabolic and repair literature, and most of what exists is rodent EEG work. DSIP (delta sleep-inducing peptide, CAS 62568-57-4) is where the category starts: Schoenenberger and Monnier isolated the nonapeptide in 1977 from the blood of rabbits in induced slow-wave sleep, and nearly fifty years later no receptor for it has been cloned. Two other lines survive scrutiny. Hypothalamic GHRH signalling has a documented relationship with non-REM slow-wave activity that appears separable from its effect on pituitary GH output, and Sermorelin is the minimal fully active GHRH fragment; Ipamorelin covers the ghrelin-receptor side of the same axis. Epithalon's older pineal literature concerns clock-gene expression and the enzymes upstream of melatonin synthesis. None of these is a sedative, and none is a GABA-A agonist.
Overview
Three research lines meet on this page and they do not share a mechanism. DSIP is the oldest and the least explained: a functional definition from one 1977 preparation, replicated unevenly since, with blood-brain barrier transport and an effect on CRF-induced corticosterone release standing up better than the sleep result the compound is named for. The somatotropic line is better grounded. GH secretion is normally locked to the first hours of non-REM sleep, and the GHRH literature indicates that slow-wave activity is driven at preoptic and anterior hypothalamic sites rather than at the pituitary — a dissociation that makes GHRH analogs useful for asking which half of the association carries the effect. Ipamorelin belongs here because GHSR-1a reaches the somatotroph through Gq and calcium instead of cAMP, so pairing it with a GHRH analog separates the routes. Epithalon comes from a different direction again: its pineal work, which predates the telomerase claims attached to the same molecule, reports effects on Clock, Csnk1e and Cry2 transcription and on AANAT and ASMT activity. Read all of it as animal and cell-model research. Human sleep-architecture data on these specific compounds is scarce.
Recommended Peptides for Sleep Research
DSIP (Delta Sleep-Inducing Peptide)
The compound with the strongest claim to this page and the weakest mechanism on it — both at once, which is why it leads. Sequence WAGGDASGE, 848.8 Da, isolated in 1977 from cerebral venous blood of rabbits in induced slow-wave sleep and named for that assay. No receptor has ever been cloned, replication of the delta-EEG finding has been uneven across laboratories, and it is not a GABA-A agonist. What has held up is blood-brain barrier transport and a reduction in CRF-induced corticosterone release. Use it as the reference compound the field is built around, not as a compound with a known target.
Sermorelin
GHRH(1-29)NH2 — the fragment that retains essentially full activity at GHRH-R once the non-binding C-terminal residues are deleted. It carries no protective modification, so DPP-IV cleaves it at Ala2 and plasma half-life runs roughly 10 to 20 minutes. That short exposure is the point when the research question is the timing of slow-wave activity rather than total hormone output.
Ipamorelin
The ghrelin-receptor arm of the same axis. GHSR-1a couples to Gq, so running it against a GHRH analog attributes an effect to one second-messenger route or the other. Its low ACTH and cortisol activity matters specifically here: HPA-axis activation confounds any sleep-architecture endpoint it touches.
Epithalon
The circadian entry rather than the somatotropic one. Reported effects on Clock, Csnk1e and Cry2 transcription and on AANAT and ASMT activity — the enzymes sitting upstream of melatonin output — place it in pineal signalling models. This arm of the Epithalon record is older and better grounded than the telomerase claims made for the same tetrapeptide.
Frequently Asked Questions
What peptides are studied in sleep and circadian research?
DSIP, the nonapeptide the field takes its name from; GHRH-R agonists such as Sermorelin; GHSR-1a agonists such as Ipamorelin; and Epithalon on the pineal side. The two secretagogues connect to non-REM slow-wave activity through the somatotropic axis, Epithalon to clock-gene and melatonin-synthesis endpoints, and DSIP to a delta-EEG assay from 1977 that has never been tied to a receptor. All are studied in animal and cell models, for laboratory research only.
Why does DSIP lead this page if its mechanism is unknown?
Because relevance and mechanism are separate questions, and conflating them would misrepresent the field. DSIP (CAS 62568-57-4) was isolated in 1977 from the cerebral venous blood of rabbits in induced slow-wave sleep and gave the sleep-peptide category its name, so no honest survey of it can leave the compound out. What a researcher then needs to know is that no DSIP receptor has been cloned, that the delta-EEG finding replicated unevenly across laboratories, and that its name recognition considerably exceeds its characterised pharmacology. Both facts belong on the page.
Is the evidence base for sleep peptides strong?
No, and saying otherwise would be dishonest. Sleep is a small corner of peptide research, dominated by rodent EEG preparations with inconsistent scoring criteria across laboratories. The GHRH literature is the strongest thread available, and even there most of the work concerns the native hormone rather than the synthetic analogs sold as research compounds.
Do any of these compounds act as sedatives?
None of them, and DSIP is the one worth naming explicitly because the claim attaches to it most often. DSIP is not a GABA-A receptor agonist; it does not produce the pharmacological signature of benzodiazepines or barbiturates in standard assays, and neither does anything else on this page. Whatever modulation of sleep-regulatory circuitry appears in this literature operates upstream of the classical sedative targets, which is precisely why it is studied.
Can a GHRH analog and a GHRP be studied together here?
Yes, and it is the standard comparative design. Sermorelin acts at GHRH-R through Gs and cAMP, Ipamorelin at GHSR-1a through Gq and calcium, and the two converge on one somatotroph. Co-stimulation gives a larger GH response than either alone — see the Ipamorelin vs Sermorelin comparison for how the two are separated.
References
- Schoenenberger GA, Monnier M. Characterization of a delta-electroencephalogram(-sleep)-inducing peptide. Proc Natl Acad Sci U S A. 1977. Read Schoenenberger and Monnier's 1977 isolation and characterization of DSIP
- Banks WA, Kastin AJ, Coy DH. Evidence that [125I]N-Tyr-delta sleep-inducing peptide crosses the blood-brain barrier by a non-competitive mechanism. Brain Res. 1984. Read Banks, Kastin and Coy on DSIP blood-brain barrier transport
- Graf MV, Kastin AJ, Coy DH, Fischman AJ. Delta-sleep-inducing peptide reduces CRF-induced corticosterone release. Neuroendocrinology. 1985. Read Graf et al. on DSIP's effect on CRF-induced corticosterone release
- Prakash A, Goa KL. "Sermorelin: A Review of its Use in the Diagnosis and Treatment of Children with Idiopathic Growth Hormone Deficiency." BioDrugs, 1999. Read the sermorelin clinical review on PubMed
- Mayo KE. "Molecular Cloning and Expression of a Pituitary-Specific Receptor for Growth Hormone-Releasing Hormone." Molecular Endocrinology, 1992. Read the GHRH receptor cloning and cAMP-signaling study on PubMed
- Wehrenberg WB, Ling N. "In Vivo Biological Potency of Rat and Human Growth Hormone-Releasing Factor and Fragments of Human Growth Hormone-Releasing Factor." Biochemical and Biophysical Research Communications, 1983. Read the GRF fragment structure-activity study on PubMed
- For contrast, the tesamorelin clinical dataset is the closest thing to modern human pharmacology for any GHRH analog. Falutz J, et al. AIDS, 2008. Read the tesamorelin long-term safety study on PubMed
- Raun K, et al. "Ipamorelin, the First Selective Growth Hormone Secretagogue." European Journal of Endocrinology, 1998. Read the Raun ipamorelin selectivity study on PubMed
- Smith RG, et al. "Modulation of Pulsatile GH Release Through a Novel Receptor in Hypothalamus and Pituitary Gland." Recent Progress in Hormone Research, 1996. Read the GH secretagogue receptor and phospholipase C signaling review on PubMed
- Bowers CY, Momany FA, Reynolds GA, Hong A. "On the In Vitro and In Vivo Activity of a New Synthetic Hexapeptide That Acts on the Pituitary to Specifically Release Growth Hormone." Endocrinology, 1984. Read the founding Bowers GHRP hexapeptide study on PubMed
- Khavinson VKh, Bondarev IE, Butyugov AA. "Epithalon Peptide Induces Telomerase Activity and Telomere Elongation in Human Somatic Cells." Bulletin of Experimental Biology and Medicine. 2003. Read the Khavinson 2003 Epithalon telomerase induction study
- Khavinson VKh, Bondarev IE, Butyugov AA, Smirnova TD. "Peptide Promotes Overcoming of the Division Limit in Human Somatic Cells." Bulletin of Experimental Biology and Medicine, 2004. Read the Khavinson 2004 replicative senescence delay study on PubMed
- Ivko OM, Linkova NS, Ilina AR, Sharova AA, Ryzhak GA. "AEDG Peptide Regulates Human Circadian Rhythm Genes Expression during Pineal Gland Accelerated Aging." Advances in Gerontology (Uspekhi Gerontologii). 2020. Read the Ivko 2020 AEDG peptide circadian gene expression study
- FDA drug approvals and databases: the authoritative record of approved drug products in the United States. Epithalon does not appear in it, which is the primary source behind the regulatory statement on this page. Search the FDA drug approval databases
Compare These Compounds
Explore More Research Areas
Browse All Research Peptides
Explore our complete catalog of HPLC-verified research peptides. Every product includes a Certificate of Analysis documenting purity and identity. Same-day US shipping on orders before 2 PM EST. For in-vitro laboratory research use only.
Browse CatalogHow This Page Is Sourced
Compiled by the Peptide.Express Research Team. Reviewed by Ben Laythee, Lead Chemist. Molecular identity on this page — name, CAS number, molecular formula and molecular weight — is resolved from a single internal entity record and checked against primary registries (PubChem, CAS Common Chemistry) rather than retyped per page. A field with no verified value is left out instead of estimated. Literature is cited to a DOI, PMID or PMCID permalink so every reference resolves to the specific record it names.